Outcomes | | | |
Mortality, % (n) | 6.5% (43/660) | 1.3% (14/1165) | <0.001 |
Duration of ICU stay (days) | 2.6 (1.4–5.9) | 1.2 (0.7–2.1) | <0.001 |
| | | |
Demographic data | | | |
Predicted mortality from APACHE II | 7.0% (95% CI 6.3% to 7.6%) | 2.4% (95% CI 2.3% to 2.7%) | <0.001 |
Age (years) | 43.6 (18.3) | 37.5 (18.1) | <0.001 |
Proportion ⩽16 years | 4.7% (32/681) | 9.7% (118/1211) | <0.001 |
Proportion > 45 years | 45.5% (312/685) | 29.9% (363/1213) | <0.001 |
Proportion with chronic respiratory disease* | 16.8% (129/685) | 16.8% (204/1213) | 0.998 |
Proportion female | 64% (438/685) | 65% (791/1213) | 0.562 |
| | | |
Physiology | | | |
Pulse | 132 (24) | 132 (23) | 0.927 |
Mean arterial blood pressure (mm Hg) | 86 (1.1) | 87 (0.6) | 0.253 |
pH from ABG with lowest Pao2 | 7.18 (0.15) | 7.34 (0.11) | <0.001 |
Paco2 from ABG with lowest pH (kPa) | 9.32 (4.36) | 6.07 (2.91) | <0.001 |
Bicarbonate (mmol) | 24.0 (6.5) | 22.3 (5.9) | <0.001 |
Lowest Pao2 (kPa) | 22.13 (15.87) | 15.73 (9.33) | <0.001 |
Pao2/Fio2 ratio | 277 (171) | 275 (148) | 0.844 |
Glasgow coma score | 12.2 (4.5) | 14.7 (1.5) | <0.001 |
Urea (mmol/l) | 6.60 (0.22) | 6.28 (0.26) | 0.401 |
Creatinine (μmol/l) | 94.3 (2.6) | 78.9 (0.9) | <0.001 |